Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Advanced Therapy Medicinal Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Advanced Therapy Medicinal Products is estimated at US$10.8 Billion in 2023 and is projected to reach US$24.0 Billion by 2030, growing at a CAGR of 12.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The growth in the ATMP market is driven by several factors. Firstly, the increasing prevalence of chronic and genetic diseases, which are often inadequately addressed by traditional treatments, is driving demand for innovative therapies like ATMPs. Secondly, significant advancements in biotechnology and genetic engineering are enabling the development of more effective and personalized ATMPs. Thirdly, substantial investments in research and development by biotech firms and pharmaceutical companies are accelerating the discovery and commercialization of new ATMPs.
Additionally, the favorable regulatory environment and expedited approval pathways for breakthrough therapies are facilitating faster market entry for ATMPs. Lastly, the growing patient and physician awareness of the benefits of advanced therapies, coupled with the expanding infrastructure for ATMP manufacturing and distribution, are further propelling the market's growth.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Tissue Engineered Products segment, which is expected to reach US$10.0 Billion by 2030 with a CAGR of a 12.9%. The Cell Therapy segment is also set to grow at 11.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $4.8 Billion in 2023, and China, forecasted to grow at an impressive 10.5% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bluebird Bio Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Advanced Therapy Medicinal Products Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 436 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $10.8 Billion |
| Forecasted Market Value (USD) by 2030 | $24 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
MARKET OVERVIEW
- A Prelude to Advanced Therapy Medicinal Products (ATMP)
- ATMPs' Costs and Availability
- Global Economic Outlook
- Global Market Prospects and Outlook
- Advanced Therapy Medicinal Products Market Poised to Witness Rapid Growth
- Growth Drivers and Challenges
- ATMP Marketing Authorisations: An Insight
- North America and Europe Dominate, Asia-Pacific to Exhibit Fastest Growth
- Competition
- Recent Market Activity
- Advanced Therapy Medicinal Products - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders Drive Market Demand
- Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Regenerative Medicine: A Promising Area for Advanced Therapy Medicinal Products
- Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
- Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2022
- Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
- Rising Demand for Gene Therapy Spurs Market Expansion
- List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
- Top Ten Genetic Diseases Worldwide
- Oncology Represents the Largest Indication for Gene Therapy
- Uptrend in Healthcare Spending Creates Fertile Environment
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Expanding Role of Advanced Therapy Medicinal Products Market in Personalized Medicine
- Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
- World Personalized Medicine Market by Region/Country (2022): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
- Biotech Research Spending Patterns Steer Momentum
FOCUS ON SELECT PLAYERS(Total 190 Featured)
- Bluebird Bio Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- JCR Pharmaceuticals Co. Ltd.
- Kolon TissueGene, Inc.
- MEDIPOST Co., Ltd.
- Novartis AG
- Organogenesis Inc.
- Spark Therapeutics, Inc.
- UniQure N.V.
- Vericel Corporation
For more information about this report visit https://www.researchandmarkets.com/r/q9fj0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
